Company intelligence / Profile preview

Supplement Formulators

Ownership: Private
Development stage: Other

Overview

Supplement Formulators, Inc. is conducting multiple double-blind, randomized, placebo-controlled clinical studies on proprietary formulations such as butyrate and butyrate + polyphenol blends for gut health and theanine-based products for stress relief. These studies focus on evaluating effects on gut permeability, associated symptoms, stress levels, mood, sleep quality, and burnout components. As of early 2025 at least two clinical trials are actively recruiting participants[1].

Therapeutic areas: PsychiatryGastroenterologyNeurology
Modalities: Small moleculeBiologic (nutraceuticals)Combination product (e.g., butyrate + polyphenol)
Industry: Food & Nutrition

Beyond the preview

Go deeper on Supplement Formulators.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supplement Formulators.

Explore the full profile